{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T11:59:29Z","timestamp":1789387169394,"version":"build-2803163510"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2006,6,1]],"date-time":"2006-06-01T00:00:00Z","timestamp":1149120000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Eur J Clin Microbiol Infect Dis"],"published-print":{"date-parts":[[2006,6]]},"DOI":"10.1007\/s10096-006-0149-4","type":"journal-article","created":{"date-parts":[[2006,5,31]],"date-time":"2006-05-31T11:34:50Z","timestamp":1149075290000},"page":"382-388","source":"Crossref","is-referenced-by-count":81,"title":["Influence of type of cancer and hematopoietic stem cell transplantation on clinical presentation of Pneumocystis jiroveci pneumonia in cancer patients"],"prefix":"10.1007","volume":"25","author":[{"given":"H. A.","family":"Torres","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R. F.","family":"Chemaly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Storey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E. A.","family":"Aguilera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G. M.","family":"Nogueras","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Safdar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K. V. I.","family":"Rolston","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I. I.","family":"Raad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D. P.","family":"Kontoyiannis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2006,6,1]]},"reference":[{"key":"149_CR1","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1001\/jama.1992.03480060078034","volume":"267","author":"KA Sepkowitz","year":"1992","unstructured":"Sepkowitz KA, Brown AE, Telzak EE, Gottlieb S, Armstrong D (1992) Pneumocystis carinii pneumonia among patients without AIDS at a cancer hospital. JAMA 267:832\u2013837","journal-title":"JAMA"},{"key":"149_CR2","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.3201\/eid1010.030985","volume":"10","author":"A Morris","year":"2004","unstructured":"Morris A, Lundgren JD, Masur H, Walzer PD, Hanson DL, Frederick T et al (2004) Current epidemiology of Pneumocystis pneumonia. Emerg Infect Dis 10:1713\u20131720","journal-title":"Emerg Infect Dis"},{"issue":"Suppl 2","key":"149_CR3","doi-asserted-by":"crossref","first-page":"S416","DOI":"10.1093\/clinids\/17.Supplement_2.S416","volume":"17","author":"KA Sepkowitz","year":"1993","unstructured":"Sepkowitz KA (1993) Pneumocystis carinii pneumonia in patients without AIDS. Clin Infect Dis 17(Suppl 2):S416\u2013S422","journal-title":"Clin Infect Dis"},{"key":"149_CR4","first-page":"333","volume":"14","author":"TC Schliep","year":"1999","unstructured":"Schliep TC, Yarrish RL (1999) Pneumocystis carinii pneumonia. Semin Respir Infect 14:333\u2013343","journal-title":"Semin Respir Infect"},{"key":"149_CR5","doi-asserted-by":"crossref","first-page":"83","DOI":"10.7326\/0003-4819-80-1-83","volume":"80","author":"PD Walzer","year":"1974","unstructured":"Walzer PD, Perl DP, Krogstad DJ, Rawson PG, Schultz MG (1974) Pneumocystis carinii pnenumonia in the United States. Epidemiologic, diagnostic, and clinical features. Ann Intern Med 80:83\u201393","journal-title":"Ann Intern Med"},{"key":"149_CR6","doi-asserted-by":"crossref","first-page":"2487","DOI":"10.1056\/NEJMra032588","volume":"350","author":"CF Thomas Jr","year":"2004","unstructured":"Thomas CF Jr, Limper AH (2004) Pneumocystis pneumonia. N Engl J Med 350:2487\u20132498","journal-title":"N Engl J Med"},{"key":"149_CR7","doi-asserted-by":"crossref","first-page":"1828","DOI":"10.1016\/S0140-6736(03)14904-5","volume":"362","author":"MS Lionakis","year":"2003","unstructured":"Lionakis MS, Kontoyiannis DP (2003) Glucocorticoids and invasive fungal infections. Lancet 362:1828\u20131838","journal-title":"Lancet"},{"key":"149_CR8","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1086\/339548","volume":"34","author":"KA Sepkowitz","year":"2002","unstructured":"Sepkowitz KA (2002) Opportunistic infections in patients with and patients without acquired immunodeficiency syndrome. Clin Infect Dis 34:1098\u20131107","journal-title":"Clin Infect Dis"},{"key":"149_CR9","first-page":"114","volume":"7","author":"KA Sepkowitz","year":"1992","unstructured":"Sepkowitz KA (1992) Pneumocystis carinii pneumonia among patients with neoplastic disease. Semin Respir Infect 7:114\u2013121","journal-title":"Semin Respir Infect"},{"key":"149_CR10","first-page":"1283","volume":"120","author":"JD Meyers","year":"1979","unstructured":"Meyers JD, Pifer LL, Sale GE, Thomas ED (1979) The value of Pneumocystis carinii antibody and antigen detection for diagnosis of Pneumocystis carinii pneumonia after marrow transplantation. Am Rev Respir Dis 120:1283\u20131287","journal-title":"Am Rev Respir Dis"},{"key":"149_CR11","doi-asserted-by":"crossref","first-page":"663","DOI":"10.7326\/0003-4819-100-5-663","volume":"100","author":"JA Kovacs","year":"1984","unstructured":"Kovacs JA, Hiemenz JW, Macher AM et al (1984) Pneumocystis carinii pneumonia: a comparison between patients with the acquired immunodeficiency syndrome and patients with other immunodeficiencies. Ann Intern Med 100:663\u2013671","journal-title":"Ann Intern Med"},{"key":"149_CR12","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1097\/00000441-200101000-00009","volume":"321","author":"DA Russian","year":"2001","unstructured":"Russian DA, Levine SJ (2001) Pneumocystis carinii pneumonia in patients without HIV infection. Am J Med Sci 321:56\u201365","journal-title":"Am J Med Sci"},{"key":"149_CR13","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1164\/ajrccm\/140.5.1204","volume":"140","author":"AH Limper","year":"1989","unstructured":"Limper AH, Offord KP, Smith TF, Martin WJ 2nd (1989) Pneumocystis carinii pneumonia. Differences in lung parasite number and inflammation in patients with and without AIDS. Am Rev Respir Dis 140:1204\u20131209","journal-title":"Am Rev Respir Dis"},{"key":"149_CR14","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1007\/s10096-002-0758-5","volume":"21","author":"F Roblot","year":"2002","unstructured":"Roblot F, Godet C, Le Moal G et al (2002) Analysis of underlying diseases and prognosis factors associated with Pneumocystis carinii pneumonia in immunocompromised HIV-negative patients. Eur J Clin Microbiol Infect Dis 21:523\u2013531","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"149_CR15","unstructured":"Centers for Disease Control (1993) Revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults. MMWR Morbid Mortal Wkly Rep 41:no. RR-17"},{"key":"149_CR16","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/S1083-8791(00)70050-4","volume":"6","author":"MJ Vasconcelles","year":"2000","unstructured":"Vasconcelles MJ, Bernardo MV, King C, Weller EA, Antin JH (2000) Aerosolized pentamidine as pneumocystis prophylaxis after bone marrow transplantation is inferior to other regimens and is associated with decreased survival and an increased risk of other infections. Biol Blood Marrow Transplant 6:35\u201343","journal-title":"Biol Blood Marrow Transplant"},{"key":"149_CR17","doi-asserted-by":"crossref","first-page":"5","DOI":"10.4065\/71.1.5","volume":"71","author":"SH Yale","year":"1996","unstructured":"Yale SH, Limper AH (1996) Pneumocystis carinii pneumonia in patients without acquired immunodeficiency syndrome: associated illness and prior corticosteroid therapy. Mayo Clin Proc 71:5\u201313","journal-title":"Mayo Clin Proc"},{"key":"149_CR18","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1046\/j.1365-2141.2002.03419.x","volume":"117","author":"L Pagano","year":"2002","unstructured":"Pagano L, Fianchi L, Mele L et al (2002) Pneumocystis carinii pneumonia in patients with malignant haematological diseases: 10 years\u2019 experience of infection in GIMEMA centres. Br J Haematol 117:379\u2013386","journal-title":"Br J Haematol"},{"key":"149_CR19","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1038\/sj.bjc.6602412","volume":"92","author":"LJ Worth","year":"2005","unstructured":"Worth LJ, Dooley MJ, Seymour JF, Mileshkin L, Slavin MA, Thursky KA (2005) An analysis of the utilisation of chemoprophylaxis against Pneumocystis jiroveci pneumonia in patients with malignancy receiving corticosteroid therapy at a cancer hospital. Br J Cancer 92:867\u2013872","journal-title":"Br J Cancer"},{"key":"149_CR20","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1007\/s10096-004-1140-6","volume":"23","author":"VC Cheng","year":"2004","unstructured":"Cheng VC, Hung IF, Wu AK, Tang BS, Chu CM, Yuen KY (2004) Lymphocyte surge as a marker for immunorestitution disease due to Pneumocystis jiroveci pneumonia in HIV-negative immunosuppressed hosts. Eur J Clin Microbiol Infect Dis 23:512\u2013514","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"149_CR21","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1097\/00005382-199901000-00003","volume":"14","author":"G McGuinness","year":"1999","unstructured":"McGuinness G, Gruden JF (1999) Viral and Pneumocystis carinii infections of the lung in the immunocompromised host. J Thorac Imaging 14:25\u201336","journal-title":"J Thorac Imaging"},{"key":"149_CR22","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1001\/archinte.1990.00390140027007","volume":"150","author":"AE Glatt","year":"1990","unstructured":"Glatt AE, Chirgwin K (1990) Pneumocystis carinii pneumonia in human immunodeficiency virus-infected patients. Arch Intern Med 150:271\u2013279","journal-title":"Arch Intern Med"},{"key":"149_CR23","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1378\/chest.113.5.1215","volume":"113","author":"JG Pareja","year":"1998","unstructured":"Pareja JG, Garland R, Koziel H (1998) Use of adjunctive corticosteroids in severe adult non-HIV Pneumocystis carinii pneumonia. Chest 113:1215\u20131224","journal-title":"Chest"},{"key":"149_CR24","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1378\/chest.105.3.650","volume":"105","author":"TD Bigby","year":"1994","unstructured":"Bigby TD (1994) Diagnosis of Pneumocystis carinii pneumonia. How invasive? Chest 105:650\u2013652","journal-title":"Chest"},{"key":"149_CR25","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1378\/chest.118.3.712","volume":"118","author":"NG Mansharamani","year":"2000","unstructured":"Mansharamani NG, Balachandran D, Vernovsky I, Garland R, Koziel H (2000) Peripheral blood CD4+ T-lymphocyte counts during Pneumocystis carinii pneumonia in immunocompromised patients without HIV infection. Chest 118:712\u2013720","journal-title":"Chest"},{"key":"149_CR26","first-page":"651","volume":"25","author":"V Barbounis","year":"2005","unstructured":"Barbounis V, Aperis G, Gambletsas E et al (2005) Pneumocystis carinii pneumonia in patients with solid tumors and lymphomas: predisposing factors and outcome. Anticancer Res 25:651\u2013655","journal-title":"Anticancer Res"},{"key":"149_CR27","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1002\/1097-0142(19930115)71:2<481::AID-CNCR2820710232>3.0.CO;2-S","volume":"71","author":"I Varthalitis","year":"1993","unstructured":"Varthalitis I, Aoun M, Daneau D, Meunier F (1993) Pneumocystis carinii pneumonia in patients with cancer. An increasing incidence. Cancer 71:481\u2013485","journal-title":"Cancer"},{"key":"149_CR28","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1086\/342338","volume":"35","author":"JR Zahar","year":"2002","unstructured":"Zahar JR, Robin M, Azoulay E, Fieux F, Nitenberg G, Schlemmer B (2002) Pneumocystis carinii pneumonia in critically ill patients with malignancy: a descriptive study. Clin Infect Dis 35:929\u2013934","journal-title":"Clin Infect Dis"},{"key":"149_CR29","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1016\/S0140-6736(03)14472-8","volume":"362","author":"DW Denning","year":"2003","unstructured":"Denning DW (2003) Echinocandin antifungal drugs. Lancet 362:1142\u20131151","journal-title":"Lancet"},{"key":"149_CR30","doi-asserted-by":"crossref","first-page":"1985","DOI":"10.1128\/AAC.42.8.1985","volume":"42","author":"MA Powles","year":"1998","unstructured":"Powles MA, Liberator P, Anderson J et al (1998) Efficacy of MK-991 (L-743,872), a semisynthetic pneumocandin, in murine models of Pneumocystis carinii. Antimicrob Agents Chemother 42:1985\u20131989","journal-title":"Antimicrob Agents Chemother"},{"key":"149_CR31","doi-asserted-by":"crossref","first-page":"5950","DOI":"10.1073\/pnas.87.15.5950","volume":"87","author":"DM Schmatz","year":"1990","unstructured":"Schmatz DM, Romancheck MA, Pittarelli LA et al (1990) Treatment of Pneumocystis carinii pneumonia with 1,3-beta-glucan synthesis inhibitors. Proc Natl Acad Sci USA 87:5950\u20135954","journal-title":"Proc Natl Acad Sci USA"},{"key":"149_CR32","doi-asserted-by":"crossref","first-page":"2259","DOI":"10.1128\/AAC.44.9.2259-2262.2000","volume":"44","author":"M Ito","year":"2000","unstructured":"Ito M, Nozu R, Kuramochi T et al (2000) Prophylactic effect of FK463, a novel antifungal lipopeptide, against Pneumocystis carinii infection in mice. Antimicrob Agents Chemother 44:2259\u20132262","journal-title":"Antimicrob Agents Chemother"},{"key":"149_CR33","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1086\/322606","volume":"33","author":"MM McNeil","year":"2001","unstructured":"McNeil MM, Nash SL, Hajjeh RA et al (2001) Trends in mortality due to invasive mycotic diseases in the United States, 1980\u20131997. Clin Infect Dis 33:641\u2013647","journal-title":"Clin Infect Dis"}],"container-title":["European Journal of Clinical Microbiology &amp; Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10096-006-0149-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10096-006-0149-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10096-006-0149-4","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,29]],"date-time":"2019-05-29T05:30:24Z","timestamp":1559107824000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10096-006-0149-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,6]]},"references-count":33,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2006,6]]}},"alternative-id":["149"],"URL":"https:\/\/doi.org\/10.1007\/s10096-006-0149-4","relation":{},"ISSN":["0934-9723","1435-4373"],"issn-type":[{"value":"0934-9723","type":"print"},{"value":"1435-4373","type":"electronic"}],"subject":[],"published":{"date-parts":[[2006,6]]}}}